Sarepta Plunged After Adverse Event Forces Trial Halt in the UK Post author:Sam Post published:February 11, 2018 Post category:BioPharma But the biotech swiftly indicated that it doesn’t expect the halt to last for long. Source: BioSpace You Might Also Like 7 Biotechs and Pharmas That Have the Potential to Double (or More) May 31, 2017 M&A Chatter Swirls Over Amgen's $70B Cashpile February 1, 2018 FDA Advisory Panel Spurns Pacira's Request for Expanded Use of Pain Drug Exparel February 15, 2018
